Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
June 10, 2019

Crystal Lake, Illinois, June 10, 2019 – AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.
 
Gateway Analytical Presents on Analytical Testing Methods for Inhalable Drug Products at Medicon Valley Inhalation Symposium
October 11, 2017

Gibsonia, PA – Gateway Analytical announces participation in the 6th Medicon Valley Inhalation Symposium (MVIS) in Lund, Sweden being held on October 11-12, 2017. Gateway Analytical will serve as one of the platinum sponsors for the conference, as well as participating in two scientific presentations about analytical testing services for respiratory drug products, developed in collaboration with Next Breath and Circassia.
 
DDL and Gateway Analytical Announce Joint Agreement
September 18, 2017
Gateway Analytical is proud to announce our partnership with DDL, allowing both companies the opportunity to offer complementary testing services to the pharmaceutical, biotech and medical device industries.
 
Say Hi to HIAC
February 22, 2017
Recently we sat down with Emily Landsperger, Scientist II at Gateway Analytical, to discuss our new HIAC testing service for USP and Compliance.
 
Gateway Analytical Now Offers Foreign Particulate Testing for Cytotoxic Pharmaceutical Products
December 12, 2016
Gateway Analytical has expanded service offerings to provide complete foreign particulate testing, identification and analysis services for cytotoxic drug products.
 
Gateway Analytical Now Offers HIAC Particle Counting and Sizing
December 06, 2016
Gateway Analytical now offers HIAC particle counting and sizing services as a response to the needs of pharmaceutical and medical device manufacturers.
 
Gateway Analytical Promotes Expertise in Foreign Particulate Testing Services at the Contract Pharma 2016 Contracting & Outsourcing Conference
September 22, 2016
Our team will be focusing on supporting pharmaceutical drug manufacturing quality control including particulate contamination identification, root cause analysis, glass delamination analysis, deviation, and out-of-specification investigation support.
 
Gateway Analytical Promotes Expertise in Foreign Particulate Testing Services at the 2016 PDA Universe of Pre-filled Syringes and Injection Devices Conference
September 19, 2016
Visit Gateway at the 2016 PDA Universe Pre-filled Syringes and Injection Devices to learn more about our expedited solutions for your most challenging foreign particulate identification needs.